Aronson Partners with BioHealth Innovation

Share Button

Aronson’s Technology Industry Services Group is partnering with Rich Bendis and BioHealth Innovation (BHI) to help transform Central Maryland into a leading biohealth entrepreneurial and commercialization region.

“The central Maryland region is home to research organizations, government agencies, universities and companies with extensive biohealth experience and capabilities,” remarked Alan Langelli, Senior Manager in Aronson’s Technology Industry Services Group.  He continued, “Aronson is very excited about the opportunity to partner with BHI and support its goal of helping Central Maryland become a leading biohealth entrepreneurial and commercialization region.”

Mr. Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries. He was voted one of the Top 5 Speakers on innovation economy in 2012.  You can see him at the South by Southwest (SXSW) Conference which takes place from March 8-17 in Austin, Texas. Mr. Bendis will be speaking on March 9th at a session titled “Entrepreneurs in Residence: Not Just for VCs.” In his presentation, Richard will introduce the BioHealth Innovation, Inc. EIR program and speak about some of the commercialization challenges being addressed creatively by the biohealth community in Maryland.

The central Maryland region has unmatched biohealth assets from iconic federal institutions, world-class universities, top-notch healthcare facilities, and global and emerging bioscience companies. However, the region has yet to fully realize the return on investment from these assets. This is largely due to the lack of a cohesive strategy in moving ideas from labs to the market. It is time central Maryland started to close this gap, and it is BioHealth Innovation’s mission to complete.

BHI sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It aims to:

  • Increase the flow of private and public early stage capital;
  • Develop an active commercialization talent network;
  • Facilitate accelerated tech transfer and commercialization of relevant innovations;
  • Market and brand the region as a global biohealth leader; and
  • Ensure an adequate supply of experienced biohealth entrepreneurs and workers.

Click here to learn more about BHI.

 

About Alan Langelli

Alan Langelli has written 1 post in this blog.

View Archives

Blog Authors

Latest Webinar Videos